先天性遺伝子または染色体異常市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）、2023年最新版

単遺伝子疾患（嚢胞性線維症、血色素症、プロトロンビン変異など）、多遺伝子疾患（喘息、動脈硬化、糖尿病、高血圧、骨粗鬆症など）、染色体疾患（ダウン症候群、エドワーズ症候群など）、多型（HLAタイピングなど）を検出する遺伝子検査があります。

当レポートでは、先天性遺伝子または染色体異常市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 先天性遺伝子または染色体異常 - 開発段階別パイプライン製品
• 先天性遺伝子または染色体異常 - 地域別パイプライン製品
• 先天性遺伝子または染色体異常 - 規制経路別パイプライン製品
• 先天性遺伝子または染色体異常 - 推定承認日別パイプライン製品
• 先天性遺伝子または染色体異常 - 進行中の臨床試験

第4章 先天性遺伝子または染色体異常- 企業が開発中のパイプライン製品

• 先天性遺伝子または染色体異常企業- 開発段階別のパイプライン製品
• 先天性遺伝子または染色体異常- 開発段階別のパイプライン製品

第5章 先天性遺伝子または染色体異常企業と製品の概要

第6章 先天性遺伝子または染色体異常- 最近の開発

第7章 付録

List of Tables

List of Tables

• Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
• Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
• Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
• Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
• Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
• Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
• Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
• Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
• Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
• Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
• Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

Abstract

GlobalData's Medical Devices sector report, "Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Inborn Gene or Chromosome Alterations pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Genetic tests to detect monogenetic disorders (like Cystic Fibrosis, Haemochromatosis, Prothrombin Mutation etc), polygenetic disorders (like Asthma , Atherosclerosis, Diabetes, Hypertension, Osteoporosis, etc), chromosomal disorders (like Down's Syndrome, Edwards Syndrome etc), polymorphisms (like HLA-Typing etc).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Inborn Gene or Chromosome Alterations under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Inborn Gene or Chromosome Alterations Overview

3 Products under Development

• 3.1 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
• 3.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
• 3.3 Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
• 3.4 Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
• 3.5 Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

4 Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies

• 4.1 Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
• 4.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

5 Inborn Gene or Chromosome Alterations Companies and Product Overview

6 Inborn Gene or Chromosome Alterations- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer